Arq. Bras. Oftalmol. 2025; 88 (3): 10.5935/0004-2749.2024-0358
Total: 1029
J. William Harbour1; Zélia Maria Corrêa2
DOI: 10.5935/0004-2749.2024-0358
1. Ocular Oncology Service, Department of Ophthalmology, and Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX, USA
2. Ocular Oncology Service, Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA
Zelia M. Correa.
E-mail: [email protected]
Funding: This study received no specific financial support.
Disclosure of potential conflicts of interest: The authors declare no potential conflicts of interest.
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
